BioWorld Asia

Sep. 6, 2006

Avidex Moves To Next Stage Via €50M MediGene Merger

LONDON - MediGene AG is acquiring Avidex Ltd. in an all-share deal that values the UK company at €50 million (US$64.3 million). (BioWorld International) Read More

Atlas Antibodies Brings In Seed Money For Human Protein Atlas

Europe Questioning Use Of Advanced Genetic Therapies

Genetix Paying £9.6M Cash To Acquire Applied Imaging

Cerep Subsidiary Hesperion Buys Touchstone Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 3, 2026

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...